Literature DB >> 11195245

Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant.

N Crassard1, A L Souillet, F Morfin, D Thouvenot, A Claudy, Y Bertrand.   

Abstract

UNLABELLED: An HIV-negative infant presented with VZV primary infection during the maintenance therapy for megakaryoblastic leukaemia. The lesions were initially vesicular and necrotic but became verrucous and hyperkeratotic. A clinical resistance to acyclovir was suspected and confirmed by histologic and virologic studies. The patient was successfully treated by foscarnet.
CONCLUSION: resistance of VZV to acyclovir may occur after a short treatment in a non-AIDS patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11195245     DOI: 10.1080/080352500456732

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.

Authors:  Hikaru Fujii; Shizuko Harada; Tomoki Yoshikawa; Souichi Yamada; Natsumi Omura; Miho Shibamura; Takuya Inagaki; Hirofumi Kato; Shuetsu Fukushi; Masayuki Saijo
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.

Authors:  G Andrei; D Topalis; P Fiten; C McGuigan; J Balzarini; G Opdenakker; R Snoeck
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

Review 3.  Antiviral drug resistance: mechanisms and clinical implications.

Authors:  Lynne Strasfeld; Sunwen Chou
Journal:  Infect Dis Clin North Am       Date:  2010-06       Impact factor: 5.982

4.  Fatal varicella due to the vaccine-strain varicella-zoster virus.

Authors:  Jessica Leung; Subhadra Siegel; James F Jones; Cynthia Schulte; Debra Blog; D Scott Schmid; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.